Skip to content
Home/Companies/Biotech/Abbisko Healthcare

Abbisko Healthcare

Biotech·China·Active
Entry
–
Hold
–
Status
Active

Who owns Abbisko Healthcare?

Abbisko Healthcare is currently owned by The Carlyle Group through Carlyle Asia fund (2021 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Asia fund · 2021 · Growth

Key facts

HQChina
SectorBiotech

More from Carlyle Asia fund

Other portfolio companies in the same fund.

Abrigo
Abrigo
Active
SaaSUS
Acentra Health
Acentra Health
Active
HealthcareUS
AutoForm
AutoForm
Active
MobilitySwitzerland
Beautycounter
Exited 2024
ConsumerUS
Duravant
Duravant
Active
IndustrialsUS
Kokusai Kogyo Co., Ltd.
Exited 2023
IndustrialsJapan
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Abbisko Healthcare

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Abbisko Healthcare?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Abbisko Healthcare.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue